Small/JJ
Non-coding/JJ
Transfer/NN
RNA-Derived/JJ
RNA/NN
Fragments/NNS
(/(
tRFs/NNS
)/)
:/:
Their/PRP$
Biogenesis/NN
,/,
Function/NN
and/CC
Implication/NN
in/IN
Human/JJ
Diseases/NNS
./.
====================
tRNA-derived/VBN
RNA/NN
fragments/NNS
(/(
tRFs/NNS
)/)
are/VBP
an/DT
emerging/VBG
class/NN
of/IN
non-coding/JJ
RNAs/NNS
(/(
ncRNAs/NNS
)/)
./.
====================
A/DT
growing/VBG
number/NN
of/IN
reports/NNS
have/VBP
shown/VBN
that/IN
tRFs/NNS
are/VBP
not/RB
random/JJ
degradation/NN
products/NNS
but/CC
are/VBP
functional/JJ
ncRNAs/NNS
made/VBD
of/IN
specific/JJ
tRNA/NN
cleavage/NN
./.
====================
They/PRP
play/VBP
regulatory/JJ
roles/NNS
in/IN
several/JJ
biological/JJ
contexts/NNS
such/JJ
as/IN
cancer/NN
,/,
innate/JJ
immunity/NN
,/,
stress/NN
responses/NNS
,/,
and/CC
neurological/JJ
disorders/NNS
./.
====================
In/IN
this/DT
review/NN
,/,
we/PRP
summarize/VBP
the/DT
biogenesis/NN
and/CC
functions/NNS
of/IN
tRFs/NNS
./.
====================
It/PRP
is/VBZ
now/RB
well/RB
known/VBN
that/IN
mammalian/JJ
genomes/NNS
encode/VBP
,/,
in/IN
addition/NN
to/TO
protein-coding/VBG
genes/NNS
,/,
RNA/NN
molecules/NNS
that/WDT
have/VBP
no/DT
protein-coding/VBG
capacity/NN
,/,
and/CC
thus/RB
are/VBP
referred/VBN
to/TO
as/IN
non-coding/JJ
RNAs/NNS
(/(
ncRNAs/NNS
)/)
[/(
1/CD
]/)
./.
====================
Recent/JJ
high/JJ
throughput/NN
sequencing/NN
data/NNS
suggest/VBP
that/IN
there/EX
are/VBP
about/RB
four/CD
times/NNS
as/IN
many/JJ
ncRNA/JJ
transcripts/NNS
as/IN
there/EX
are/VBP
protein-coding/VBG
RNA/NN
transcripts/NNS
in/IN
human/JJ
cells/NNS
./.
====================
While/IN
some/DT
ncRNAs/NNS
,/,
such/JJ
as/IN
ribosomal/JJ
RNAs/NNS
(/(
rRNAs/NNS
)/)
,/,
transfer/NN
RNAs/NNS
(/(
tRNAs/NNS
)/)
,/,
and/CC
those/DT
well-studied/VBN
ones/NNS
including/VBG
microRNAs/NNS
(/(
miRNAs/NNS
)/)
and/CC
small/JJ
interfering/VBG
RNAs/NNS
(/(
siRNAs/NNS
)/)
,/,
are/VBP
recognized/VBN
as/IN
functional/JJ
molecules/NNS
,/,
the/DT
majority/NN
of/IN
ncRNAs/NNS
and/CC
their/PRP$
biological/JJ
roles/NNS
in/IN
mammals/NNS
are/VBP
underappreciated/VBN
,/,
as/IN
evolution/NN
would/MD
have/VBP
favored/VBN
against/IN
such/JJ
gratuitous/JJ
and/CC
wasteful/JJ
transcription/NN
[/(
2/CD
]/)
./.
====================
However/RB
,/,
accumulating/VBG
evidence/NN
has/VBZ
exhibited/VBD
a/DT
remarkable/JJ
degree/NN
of/IN
their/PRP$
involvement/NN
in/IN
many/JJ
biological/JJ
events/NNS
including/VBG
cell/NN
proliferation/NN
,/,
cellular/JJ
stress/NN
responses/NNS
,/,
host/NN
immune/JJ
responses/NNS
and/CC
virus/NN
replication/NN
[/(
3456/CD
]/)
./.
====================
Based/VBN
on/IN
their/PRP$
size/NN
,/,
ncRNAs/NNS
are/VBP
classified/VBN
into/IN
long/JJ
,/,
medium/NN
,/,
and/CC
small/JJ
ones/NNS
./.
====================
Those/DT
longer/RBR
than/IN
200/CD
nucleotides/NNS
(/(
nt/NNS
)/)
are/VBP
termed/VBN
as/IN
long/JJ
(/(
or/CC
large/JJ
)/)
ncRNAs/NNS
(/(
lncRNAs/NNS
)/)
and/CC
include/VBP
the/DT
majority/NN
of/IN
nuclear/JJ
ncRNAs/NNS
./.
====================
Those/DT
ranging/VBG
40-200/CD
nt/NNS
are/VBP
medium-sized/VBN
ncRNAs/NNS
including/VBG
many/JJ
classic/JJ
ncRNAs/NNS
such/JJ
as/IN
5S/NN
rRNA/NN
,/,
tRNAs/NNS
,/,
small/JJ
nuclear/JJ
RNAs/NNS
(/(
snRNAs/NNS
)/)
,/,
small/JJ
nucleolar/JJ
RNAs/NNS
(/(
snoRNAs/NNS
)/)
,/,
etc/JJ
./.
====================
ncRNAs/NNS
shorter/JJR
than/IN
40/CD
nt/NNS
are/VBP
termed/VBN
small/JJ
ncRNAs/NNS
(/(
sncRNAs/NNS
)/)
that/WDT
have/VBP
been/VBN
extensively/RB
studied/VBN
in/IN
the/DT
last/JJ
two/CD
decades/NNS
and/CC
will/MD
be/VB
elaborated/VBN
in/IN
the/DT
next/JJ
section/NN
./.
====================
In/IN
this/DT
review/NN
,/,
we/PRP
will/MD
focus/VB
on/IN
a/DT
recently/RB
discovered/VBN
class/NN
of/IN
sncRNAs/NNS
called/VBN
tRNA-derived/JJ
RNA/NN
fragments/NNS
(/(
tRFs/NNS
)/)
,/,
as/IN
data/NNS
from/IN
several/JJ
groups/NNS
including/VBG
those/DT
from/IN
us/PRP
suggested/VBD
them/PRP
to/TO
be/VB
emerging/VBG
functional/JJ
molecules/NNS
./.
====================
The/DT
functionality/NN
of/IN
ncRNAs/NNS
was/VBD
initially/RB
bolstered/VBN
by/IN
the/DT
discovery/NN
showing/VBG
that/IN
sncRNAs/NNS
are/VBP
capable/JJ
of/IN
mediating/VBG
both/CC
transcriptional/JJ
and/CC
post-transcriptional/JJ
gene/NN
silencing/NN
[/(
7/CD
]/)
./.
====================
The/DT
most/JJS
extensively/RB
studied/VBN
among/IN
them/PRP
are/VBP
miRNAs/NNS
that/DT
regulate/VBP
target/NN
mRNAs/NNS
post-transcriptionally/RB
in/IN
animals/NNS
and/CC
plants/NNS
[/(
8910/CD
]/)
./.
====================
Another/DT
class/NN
of/IN
sncRNAs/NNS
is/VBZ
siRNAs/NNS
that/DT
are/VBP
closely/RB
related/JJ
to/TO
miRNAs/NNS
[/(
11/CD
]/)
./.
====================
Although/IN
naturally/RB
occurring/VBG
siRNAs/NNS
have/VBP
been/VBN
reported/VBN
to/TO
be/VB
present/JJ
in/IN
some/DT
mammals/NNS
in/IN
addition/NN
to/TO
plants/NNS
and/CC
flies/NNS
[/(
1213/CD
]/)
,/,
siRNAs/NNS
are/VBP
more/RBR
renowned/VBD
as/IN
an/DT
experimental/JJ
tool/NN
in/IN
mammalian/JJ
cells/NNS
./.
====================
The/DT
gene/NN
silencing/NN
by/IN
synthetic/JJ
double-stranded/JJ
RNAs/NNS
(/(
dsRNAs/NNS
)/)
and/CC
their/PRP$
Dicer-cleavage/JJ
products/NNS
(/(
that/DT
are/VBP
siRNAs/NNS
)/)
is/VBZ
called/VBN
RNA/NN
interference/NN
(/(
RNAi/NNP
)/)
and/CC
has/VBZ
been/VBN
being/VBG
used/VBN
as/IN
a/DT
popular/JJ
gene/NN
knockdown/VBN
method/NN
[/(
3/CD
]/)
./.
====================
This/DT
technical/JJ
breakthrough/IN
was/VBD
well/RB
recognized/VBN
and/CC
celebrated/JJ
by/IN
the/DT
2006/CD
Nobel/JJ
Prize/NN
,/,
which/WDT
was/VBD
awarded/VBN
to/TO
the/DT
two/CD
scientists/NNS
who/WP
discovered/VBD
RNAi/NN
[/(
1415/CD
]/)
./.
====================
A/DT
number/NN
of/IN
other/JJ
sncRNAs/NNS
have/VBP
also/RB
been/VBN
identified/VBN
in/IN
various/JJ
organisms/NNS
[/(
1617/CD
]/)
,/,
including/VBG
piwi-interacting/VBG
RNA/NN
(/(
piRNA/JJ
)/)
,/,
repeat-associated/VBD
siRNA/JJ
(/(
rasiRNA/NN
)/)
,/,
tiny/JJ
ncRNAs/NNS
(/(
tncRNA/JJ
)/)
,/,
heterochromatic/JJ
small/JJ
RNA/NN
(/(
21U-RNA/JJ
,/,
hcRNA/NN
)/)
,/,
scan/MD
RNA/NN
(/(
scnRNA/NN
)/)
,/,
transcription/NN
initiation/NN
RNA/NN
(/(
tiRNA/JJ
)/)
[/(
18/CD
]/)
,/,
and/CC
promoter/termini-associated/JJ
sRNA/JJ
(/(
PASR/TASR/NN
)/)
[/(
19/CD
]/)
./.
====================
Although/IN
some/DT
of/IN
these/DT
have/VBP
been/VBN
shown/VBN
to/TO
play/VB
roles/NNS
in/IN
several/JJ
biological/JJ
processes/NNS
such/JJ
as/IN
heterochromatin/NN
formation/NN
and/CC
transposon/NN
silencing/NN
,/,
their/PRP$
functions/NNS
are/VBP
largely/RB
unknown/JJ
and/CC
detailed/JJ
description/NN
of/IN
them/PRP
is/VBZ
beyond/JJ
the/DT
scope/NN
of/IN
this/DT
review/NN
[/(
10/CD
]/)
./.
====================
Mature/JJ
tRNAs/NNS
are/VBP
characterized/VBN
by/IN
their/PRP$
evolutionarily/RB
conserved/VBN
secondary/JJ
and/CC
tertiary/JJ
structures/NNS
,/,
extensive/JJ
post-transcriptional/JJ
modifications/NNS
(/(
up/RB
to/TO
100/CD
nucleoside/NN
modifications/NNS
have/VBP
been/VBN
described/VBN
)/)
,/,
extreme/JJ
stability/NN
and/CC
resistance/NN
to/TO
nucleases/NNS
[/(
202122/CD
]/)
./.
====================
There/EX
are/VBP
more/RBR
than/IN
600/CD
tRNA/NN
genes/NNS
in/IN
humans/NNS
,/,
which/WDT
are/VBP
far/RB
more/RBR
than/IN
needed/VBN
for/IN
at/IN
most/JJS
64/CD
anticodons/NNS
and/CC
20/CD
amino/NN
acids/NNS
[/(
232425/CD
]/)
,/,
suggesting/VBG
gene-specific/JJ
functions/NNS
of/IN
tRNAs/NNS
other/JJ
than/IN
its/PRP$
traditional/JJ
function/NN
in/IN
linking/VBG
a/DT
codon/NN
to/TO
the/DT
cognate/JJ
amino/NN
acid/NN
during/IN
translation/NN
./.
====================
Indeed/RB
,/,
tRFs/NNS
were/VBD
recently/RB
identified/VBN
as/IN
a/DT
new/JJ
class/NN
of/IN
sncRNAs/NNS
fragmentized/VBN
from/IN
tRNAs/NNS
and/CC
shown/VBN
to/TO
be/VB
important/JJ
in/IN
regulating/VBG
cell/NN
proliferation/NN
,/,
stress-induced/JJ
translational/JJ
suppression/NN
,/,
stress/NN
granule/NN
(/(
SG/NN
)/)
assembly/RB
,/,
and/CC
virus/NN
replication/NN
./.
====================
Expression/NN
of/IN
some/DT
tRFs/NNS
is/VBZ
commonly/RB
seen/VBN
among/IN
different/JJ
organisms/NNS
,/,
further/RB
supporting/VBG
that/DT
tRFs/NNS
have/VBP
emerged/VBN
as/IN
important/JJ
players/NNS
in/IN
diverse/JJ
aspects/NNS
of/IN
biology/NN
./.
====================
A/DT
mature/JJ
tRNA/NN
has/VBZ
a/DT
5'-monophosphate/JJ
group/NN
and/CC
3'-CCA/NN
charged/VBD
with/IN
cognate/JJ
amino/NN
acid/NN
./.
====================
All/DT
properly/RB
folded/VBN
tRNAs/NNS
,/,
with/IN
so/RB
called/VBN
a/DT
cloverleaf/JJ
structure/NN
,/,
have/VBP
four/CD
base-paired/JJ
stems/NNS
(/(
in/IN
5'–3/NN
'/``
direction/NN
:/:
D/NN
arm/NN
,/,
anticodon/JJ
arm/NN
,/,
T/NN
arm/NN
,/,
and/CC
acceptor/NN
stem/NN
)/)
bridging/VBG
the/DT
conserved/VBN
D-loop/JJ
,/,
tRNA-specific/JJ
anticodon/JJ
loop/NN
,/,
variable/JJ
loop/NN
,/,
and/CC
T-loop/JJ
./.
====================
Primary/JJ
transcripts/NNS
(/(
pre-tRNAs/NNS
)/)
undergo/VBP
several/JJ
stages/NNS
of/IN
maturation/NN
before/IN
becoming/VBG
translation-competent/JJ
tRNAs/NNS
[/(
26/CD
]/)
./.
====================
Compared/VBN
to/TO
a/DT
mature/JJ
tRNA/NN
,/,
a/DT
pre-tRNA/JJ
lacks/VBZ
a/DT
CCA/NN
tail/NN
but/CC
includes/VBZ
a/DT
5'-leader/JJ
starting/VBG
with/IN
triphosphate/NN
,/,
a/DT
3'-trailer/NN
with/IN
an/DT
oligouridine/JJ
stretch/NN
and/CC
,/,
for/IN
intron-containing/VBG
tRNA/NN
,/,
a/DT
variably-sized/JJ
intron/NN
./.
====================
The/DT
5'-/JJ
and/CC
3'-end/NN
of/IN
a/DT
pre-tRNA/JJ
are/VBP
trimmed/VBN
by/IN
the/DT
endonucleases/NNS
RNase/NN
P/NN
and/CC
RNase/NN
Z/NN
respectively/RB
,/,
and/CC
an/DT
intron/NN
is/VBZ
spliced/VBN
if/IN
there/EX
is/VBZ
[/(
2728/CD
]/)
./.
====================
The/DT
'CCA/NN
'/``
acceptor/NN
stem/NN
must/MD
be/VB
added/VBN
to/TO
the/DT
3'-end/NN
as/IN
this/DT
is/VBZ
not/RB
encoded/VBN
in/IN
eukaryotes/NNS
[/(
29/CD
]/)
./.
====================
While/IN
mature/JJ
,/,
uncleaved/JJ
tRNAs/NNS
have/VBP
a/DT
well-defined/JJ
role/NN
in/IN
protein/NN
translation/NN
,/,
multiple/JJ
groups/NNS
have/VBP
cloned/VBN
and/CC
sequenced/VBN
shorter/JJR
tRNA/NN
fragments/NNS
[/(
30/CD
]/)
./.
====================
These/DT
fragments/NNS
(/(
termed/VBN
``/RB
tRFs/NNS
''/NNP
)/)
identified/VBD
so/RB
far/RB
can/MD
be/VB
classified/VBN
into/IN
three/CD
groups/NNS
;/:
tRF-5/RB
series/NNS
whose/WP$
5'-end/JJ
is/VBZ
aligned/VBN
to/TO
the/DT
5'-end/JJ
of/IN
mature/JJ
tRNA/NN
,/,
tRF-3/NN
series/NNS
whose/WP$
3'-end/NN
is/VBZ
aligned/VBN
to/TO
the/DT
3'-end/NN
of/IN
mature/JJ
tRNA/NN
,/,
and/CC
tRF-1/NN
series/NNS
which/WDT
is/VBZ
the/DT
3'-trailer/NN
sequence/NN
in/IN
a/DT
pre-tRNA/JJ
and/CC
released/VBD
during/IN
3'-end/NN
processing/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
Some/DT
groups/NNS
have/VBP
also/RB
termed/VBN
the/DT
tRF-5/NN
or/CC
tRF-3/NN
series/NN
as/IN
tRF/NN
halves/VBZ
or/CC
type/NN
I/CD
[/(
3132/CD
]/)
and/CC
tRF1/NN
series/NN
as/IN
type/NN
II/CD
[/(
32/CD
]/)
./.
====================
The/DT
tRF-5/NN
series/NN
were/VBD
the/DT
first/JJ
identified/VBD
class/NN
of/IN
tRFs/NNS
and/CC
were/VBD
usually/RB
formed/VBN
by/IN
a/DT
cleavage/NN
in/IN
the/DT
D/NN
or/CC
anticodon/JJ
loop/NN
of/IN
a/DT
mature/JJ
tRNA/NN
./.
====================
They/PRP
have/VBP
been/VBN
reported/VBN
in/IN
mammalian/JJ
cells/NNS
,/,
plants/NNS
,/,
and/CC
fission/NN
yeast/NN
[/(
333343536/CD
]/)
./.
====================
As/IN
aforementioned/VBN
,/,
the/DT
tRF-3/NN
series/NN
are/VBP
those/DT
derived/VBN
from/IN
the/DT
3'-end/NN
of/IN
a/DT
mature/JJ
tRNA/NN
,/,
usually/RB
by/IN
cleavage/NN
in/IN
the/DT
T/NN
loop/NN
[/(
332373839/CD
]/)
./.
====================
As/IN
the/DT
3'-end/NN
of/IN
mature/JJ
tRNAs/NNS
is/VBZ
the/DT
acceptor/NN
trinucleotide/NN
CCA/NN
,/,
the/DT
tRF-3/NN
series/NN
also/RB
characteristically/RB
has/VBZ
an/DT
end/NN
CCA/NN
./.
====================
The/DT
tRF-1/NN
series/NNS
are/VBP
undoubtedly/RB
the/DT
RNase/NN
Z/NN
cleavage/NN
product/NN
of/IN
a/DT
pre-tRNA/JJ
,/,
because/IN
their/PRP$
5'-ends/NNS
begin/IN
immediately/RB
after/IN
the/DT
3'-terminus/NN
of/IN
the/DT
mature/JJ
tRNA/NN
and/CC
their/PRP$
3'-ends/NNS
are/VBP
a/DT
series/NN
of/IN
U/NNP
residues/NNS
that/DT
are/VBP
residual/JJ
from/IN
RNA/NN
polymerase/NN
III/CD
transcription/NN
run-off/JJ
[/(
3324041/CD
]/)
./.
====================
Overall/RB
,/,
the/DT
cleavage/NN
of/IN
tRFs/NNS
is/VBZ
very/RB
much/RB
structure-dependent/JJ
,/,
suggesting/VBG
they/PRP
are/VBP
not/RB
randomly/RB
degraded/VBN
products/NNS
./.
====================
Other/JJ
reasons/NNS
supporting/VBG
that/DT
tRFs/NNS
are/VBP
biologically/RB
meaningful/JJ
include/VBP
their/PRP$
endonuclease-specific/JJ
cleavage/NN
[/(
343442/CD
]/)
./.
====================
The/DT
production/NN
of/IN
the/DT
tRF-5/NN
series/NN
has/VBZ
been/VBN
reported/VBN
to/TO
be/VB
Dicer/JJ
or/CC
angiogenin/NN
(/(
ANG/NN
)/)
-dependent/JJ
in/IN
mammals/NNS
[/(
3334/CD
]/)
./.
====================
In/IN
one/CD
case/NN
,/,
the/DT
tRF-5/NN
series/NNS
were/VBD
identified/VBN
to/TO
be/VB
produced/VBN
after/IN
the/DT
hybridization/NN
of/IN
the/DT
3'-end/NN
of/IN
the/DT
human/JJ
cellular/JJ
tRNAlys/NNS
with/IN
the/DT
HIV-1/NN
primer/NN
binding/VBG
site/NN
,/,
raising/VBG
the/DT
possibility/NN
that/IN
,/,
at/IN
least/JJS
in/IN
certain/JJ
cases/NNS
,/,
tRFs/NNS
may/MD
be/VB
produced/VBN
when/WRB
a/DT
tRNA/NN
base-pairs/NNS
with/IN
another/DT
RNA/NN
molecule/NN
[/(
38/CD
]/)
./.
====================
It/PRP
has/VBZ
been/VBN
reported/VBN
that/IN
the/DT
tRF-3/NN
series/NN
are/VBP
generated/VBN
by/IN
Dicer/NN
[/(
3238/CD
]/)
./.
====================
In/IN
Tetrahymena/NN
,/,
although/IN
the/DT
nuclease/NN
identity/NN
was/VBD
not/RB
proven/VBN
,/,
the/DT
tRF-3/NN
series/NN
have/VBP
5'-monophosphates/NNS
that/DT
are/VBP
usually/RB
left/NN
after/IN
Dicer/NN
cleavage/NN
and/CC
are/VBP
in/IN
physical/JJ
association/NN
with/IN
Argonaute/Piwi/NN
proteins/NNS
,/,
suggesting/VBG
Dicer-mediated/JJ
cleavage/NN
[/(
39/CD
]/)
./.
====================
The/DT
tRNA/NN
3'-trailer/NN
sequences/NNS
are/VBP
thought/VBN
to/TO
be/VB
rapidly/RB
degraded/VBN
in/IN
the/DT
nuclear/JJ
compartment/NN
soon/RB
after/IN
being/VBG
cleaved/VBN
from/IN
pre-tRNAs/NNS
./.
====================
Therefore/RB
,/,
it/PRP
is/VBZ
quite/RB
surprising/VBG
that/IN
the/DT
tRF-1/NN
series/NN
are/VBP
localized/VBN
mainly/RB
in/IN
the/DT
cytoplasm/NN
[/(
341/CD
]/)
./.
====================
There/EX
are/VBP
two/CD
explanations/NNS
on/IN
how/WRB
the/DT
tRF-1/NN
series/NNS
bypass/VB
nuclear/JJ
cleavage/NN
:/:
(/(
1/CD
)/)
the/DT
tRF-1/NN
series/NNS
are/VBP
exported/VBN
from/IN
the/DT
nucleus/NN
by/IN
an/DT
unknown/JJ
mechanism/NN
upon/IN
processing/NN
,/,
or/CC
(/(
2/CD
)/)
pre-tRNAs/VBZ
escape/VBP
nuclear/JJ
quality/NN
control/NN
and/CC
are/VBP
processed/VBN
by/IN
cytoplasmic/JJ
RNase/NN
Z/NN
./.
====================
Biological/JJ
evidence/NN
indeed/RB
supports/VBZ
the/DT
second/JJ
possibility/NN
./.
====================
At/IN
least/JJS
in/IN
one/CD
case/NN
of/IN
a/DT
tRF-1/NN
molecule/NN
derived/VBN
from/IN
tRNASer/NN
(/(
termed/VBN
tRF-1001/NN
[/(
3/CD
]/)
and/CC
Cand45/NN
[/(
32/CD
]/)
)/)
,/,
the/DT
corresponding/JJ
pre-tRNA/JJ
is/VBZ
localized/VBN
in/IN
the/DT
cytoplasm/NN
[/(
332/CD
]/)
./.
====================
Also/RB
there/EX
are/VBP
several/JJ
reports/NNS
supporting/VBG
the/DT
cytoplasmic/JJ
localization/NN
of/IN
tRNA/NN
endonucleases/NNS
responsible/JJ
for/IN
the/DT
tRF-1/NN
series/NN
[/(
343/CD
]/)
./.
====================
Are/RB
tRFs/NNS
merely/RB
by-products/VBZ
of/IN
tRNA/NN
degradation/NN
or/CC
nuclease/NN
off-target/VBP
effects/NNS
?/.
====================
Or/RB
do/VBP
they/PRP
have/VBP
bona/NN
fide/NN
biological/JJ
functions/NNS
?/.
====================
If/IN
they/PRP
do/VBP
have/VBP
functions/NNS
,/,
how/WRB
diverse/JJ
are/VBP
these/DT
functions/NNS
?/.
====================
Several/JJ
lines/NNS
of/IN
evidence/NN
have/VBP
identified/VBN
their/PRP$
regulatory/JJ
targets/NNS
,/,
supporting/VBG
that/DT
they/PRP
are/VBP
functional/JJ
molecules/NNS
[/(
31343537/CD
]/)
./.
====================
Although/IN
the/DT
exact/JJ
roles/NNS
of/IN
tRFs/NNS
are/VBP
further/RBR
to/TO
be/VB
elucidated/VBN
,/,
accumulating/VBG
evidence/NN
suggests/VBZ
that/IN
they/PRP
participate/VBP
in/IN
two/CD
main/JJ
types/NNS
of/IN
biological/JJ
processes/NNS
as/IN
discussed/VBN
in/IN
more/RBR
detail/NN
below/IN
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
tRNAs/NNS
are/VBP
indispensable/JJ
components/NNS
of/IN
the/DT
translational/JJ
machinery/NN
,/,
hence/RB
one/CD
can/MD
surmise/VB
that/DT
tRNA/NN
cleavage/NN
affects/VBZ
protein/NN
synthesis/NN
./.
====================
However/RB
,/,
the/DT
mode/NN
of/IN
translational/JJ
regulation/NN
by/IN
tRNA/NN
cleavage/NN
is/VBZ
not/RB
simply/RB
a/DT
result/NN
of/IN
change/NN
in/IN
the/DT
mature/JJ
tRNA/NN
pool/NN
available/JJ
for/IN
protein/NN
synthesis/NN
./.
====================
Ivanov/NN
et/FW
al/JJ
./.
====================
showed/VBD
that/IN
tRNA/NN
halves/VBZ
generated/VBN
by/IN
ANG/NN
during/IN
stress/NN
play/VBP
an/DT
active/JJ
role/NN
in/IN
inhibiting/VBG
protein/NN
synthesis/NN
and/CC
triggering/VBG
the/DT
phospho-eIF2α-independent/JJ
assembly/NN
of/IN
SGs/NNS
[/(
44/CD
]/)
./.
====================
In/IN
addition/NN
to/TO
tRNA/NN
halves/VBZ
,/,
tRFs/NNS
have/VBP
also/RB
been/VBN
reported/VBN
to/TO
be/VB
involved/VBN
in/IN
global/JJ
translational/JJ
inhibition/NN
in/IN
human/JJ
cells/NNS
./.
====================
In/IN
the/DT
archaeon/NN
Haloferax/NN
volcanii/NN
a/DT
26-nt/JJ
long/JJ
tRF-5/NN
originating/VBG
from/IN
tRNAVal/JJ
in/IN
a/DT
stress-dependent/JJ
manner/NN
was/VBD
shown/VBN
to/TO
directly/RB
bind/VBP
to/TO
the/DT
small/JJ
ribosomal/JJ
subunit/NN
and/CC
reduce/VBP
protein/NN
synthesis/NN
by/IN
interfering/VBG
with/IN
peptidyl/JJ
transferase/NN
activity/NN
[/(
45/CD
]/)
./.
====================
A/DT
similar/JJ
mechanism/NN
of/IN
translation/NN
inhibition/NN
by/IN
a/DT
tRF-5/NN
was/VBD
also/RB
observed/VBN
in/IN
human/JJ
cells/NNS
[/(
46/CD
]/)
./.
====================
A/DT
19-nt/JJ
long/JJ
tRF-5/NN
derived/VBN
from/IN
tRNAGln/NN
decreased/VBD
the/DT
expression/NN
of/IN
a/DT
reporter/NN
gene/NN
that/WDT
did/VBD
not/RB
have/VB
a/DT
sequence/NN
complementary/JJ
to/TO
that/DT
of/IN
the/DT
tRF-5/NN
,/,
suggesting/VBG
that/IN
non-specific/JJ
translational/JJ
repression/NN
is/VBZ
mediated/VBN
by/IN
this/DT
tRF-5/NN
./.
====================
An/DT
interesting/JJ
observation/NN
from/IN
this/DT
study/NN
was/VBD
that/DT
the/DT
tRFs/NNS
required/VBN
a/DT
conserved/VBN
``/NN
GG/NNS
''/CD
dinucleotide/NN
for/IN
their/PRP$
activity/NN
in/IN
inhibiting/VBG
translation/NN
./.
====================
Because/IN
the/DT
tRF-5/NN
series/NN
were/VBD
detected/VBN
in/IN
the/DT
polysome/NN
fraction/NN
,/,
interaction/NN
of/IN
the/DT
tRF-5/NN
with/IN
the/DT
ribosome/NN
may/MD
contribute/VB
to/TO
translation/NN
[/(
46/CD
]/)
./.
====================
In/IN
addition/NN
to/TO
above-mentioned/VBN
translational/JJ
regulation/NN
,/,
it/PRP
has/VBZ
become/VBN
apparent/JJ
that/IN
some/DT
tRFs/NNS
mediate/VBP
gene/NN
silencing/NN
similarly/RB
to/TO
miRNAs/NNS
by/IN
binding/VBG
to/TO
Argonaute/VB
family/NN
proteins/NNS
[/(
161747/CD
]/)
./.
====================
The/DT
first/JJ
tRFs/NNS
suggested/VBD
to/TO
be/VB
involved/VBN
in/IN
the/DT
gene/NN
silencing/NN
are/VBP
some/DT
tRF-5/NN
and/CC
-3/CD
molecules/NNS
[/(
32/CD
]/)
./.
====================
Haussecker/NN
et/FW
al/JJ
./.
====================
observed/VBN
that/IN
they/PRP
are/VBP
in/IN
association/NN
with/IN
Ago-3/NN
and/CC
-4/CD
and/CC
exhibit/VBP
trans-gene/JJ
silencing/NN
activity/NN
./.
====================
However/RB
,/,
this/DT
activity/NN
is/VBZ
much/RB
lower/JJR
than/IN
that/DT
of/IN
miRNAs/NNS
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
some/DT
groups/NNS
showed/VBD
that/IN
the/DT
tRF-5/NN
series/NN
have/VBP
inefficient/JJ
association/NN
with/IN
Argonautes/NNS
[/(
34/CD
]/)
and/CC
do/VBP
not/RB
exhibit/VB
detectable/JJ
silencing/NN
effects/NNS
[/(
31/CD
]/)
./.
====================
Probably/RB
the/DT
most/JJS
convincing/VBG
result/NN
is/VBZ
from/IN
our/PRP$
recent/JJ
studies/NNS
on/IN
a/DT
tRF-5/NN
molecule/NN
derived/VBN
from/IN
mature/JJ
tRNAGluCTC/NN
(/(
tRF5-GluCTC/NN
)/)
./.
====================
Upon/IN
infection/NN
of/IN
respiratory/JJ
syncytial/JJ
virus/NN
(/(
RSV/NN
)/)
,/,
tRF5-GluCTC/NN
is/VBZ
induced/VBN
robustly/RB
and/CC
plays/VBZ
a/DT
gene-silencing/JJ
role/NN
on/IN
a/DT
target/NN
mRNA/NN
with/IN
a/DT
reverse/JJ
complementary/JJ
target/NN
sequence/NN
./.
====================
In/IN
this/DT
case/NN
,/,
the/DT
trans-silencing/VBG
mechanism/NN
used/VBN
by/IN
this/DT
tRF/NN
was/VBD
distinct/JJ
from/IN
that/DT
of/IN
canonical/JJ
miRNA/siRNA/NN
./.
====================
Mutagenesis/NN
studies/NNS
demonstrated/VBD
that/IN
the/DT
3'-portion/NN
of/IN
tRF5-GluCTC/NN
is/VBZ
critical/JJ
for/IN
its/PRP$
gene/NN
silencing/NN
function/NN
,/,
in/IN
contrast/NN
to/TO
miRNAs/NNS
whose/WP$
5'-portion/JJ
is/VBZ
the/DT
key/JJ
determinant/JJ
in/IN
target/NN
recognition/NN
[/(
5/CD
]/)
./.
====================
The/DT
expression/NN
of/IN
tRFs/NNS
is/VBZ
altered/JJ
in/IN
a/DT
number/NN
of/IN
pathological/JJ
conditions/NNS
and/CC
so/RB
those/DT
tRFs/NNS
could/MD
be/VB
useful/JJ
disease/NN
biomarkers/NNS
./.
====================
The/DT
involvement/NN
of/IN
tRFs/NNS
in/IN
cancer/NN
,/,
neurodegeneration/NN
and/CC
infectious/JJ
disease/NN
will/MD
be/VB
discussed/VBN
in/IN
the/DT
following/VBG
paragraphs/NNS
(/(
Fig/NN
./.
====================
2/CD
)/)
[/(
548/CD
]/)
./.
====================
The/DT
role/NN
of/IN
tRFs/NNS
in/IN
cancer/NN
was/VBD
first/JJ
reported/VBD
by/IN
Lee/NNP
et/FW
al3/NN
./.
====================
One/CD
of/IN
the/DT
tRF-1/NN
series/NNS
(/(
namely/RB
tRF-1001/NN
)/)
,/,
derived/VBN
from/IN
pre-tRNASer/JJ
,/,
is/VBZ
highly/RB
expressed/VBN
in/IN
several/JJ
cancer/NN
cell/NN
lines/NNS
relative/JJ
to/TO
non-proliferating/JJ
normal/JJ
tissues/NNS
,/,
and/CC
is/VBZ
required/VBN
for/IN
proliferation/NN
of/IN
prostate/NN
cancer/NN
cells/NNS
[/(
3/CD
]/)
./.
====================
The/DT
levels/NNS
of/IN
tRF-1001/NN
in/IN
cancer/NN
cells/NNS
are/VBP
directly/RB
related/JJ
to/TO
the/DT
degree/NN
of/IN
cellular/JJ
proliferation/NN
./.
====================
Knocking/VBG
down/RB
this/DT
tRF/NN
causes/VBZ
a/DT
dramatic/JJ
loss/NN
of/IN
cell/NN
viability/NN
and/CC
inhibition/NN
of/IN
cell/NN
proliferation/NN
with/IN
specific/JJ
accumulation/NN
of/IN
cells/NNS
in/IN
G2/NN
phase/NN
and/CC
inhibition/NN
of/IN
DNA/NN
synthesis/NN
[/(
3/CD
]/)
./.
====================
In/IN
addition/NN
,/,
analysis/NN
of/IN
the/DT
small/JJ
RNA/NN
transcriptome/VBP
in/IN
prostate/NN
cancer/NN
revealed/VBD
enrichment/JJ
of/IN
tRFs/NNS
in/IN
both/DT
non-metastatic/JJ
and/CC
metastatic/JJ
lymph/NN
node/NN
prostate/NN
cancer/NN
samples/NNS
[/(
3/CD
]/)
./.
====================
The/DT
molecular/JJ
mechanism/NN
by/IN
which/WDT
tRF-1001/CD
affects/VBZ
cell/NN
physiology/NN
is/VBZ
not/RB
known/VBN
./.
====================
There/EX
may/MD
be/VB
a/DT
differential/JJ
processing/NN
of/IN
tRNA/NN
in/IN
prostate/NN
cancer/NN
because/IN
tRFs/NNS
in/IN
non-metastatic/JJ
samples/NNS
were/VBD
18/CD
nucleotides/NNS
long/JJ
whereas/IN
tRFs/NNS
in/IN
metastatic/JJ
tissues/NNS
were/VBD
27/CD
nucleotides/NNS
long/JJ
[/(
49/CD
]/)
./.
====================
The/DT
important/JJ
role/NN
of/IN
tRFs/NNS
in/IN
controlling/VBG
cancer/NN
is/VBZ
also/RB
supported/VBD
by/IN
the/DT
observation/NN
showing/VBG
enhanced/VBD
ANG/NN
expression/NN
in/IN
almost/RB
all/DT
types/NNS
of/IN
cancer/NN
[/(
505152/CD
]/)
./.
====================
Recently/RB
,/,
it/PRP
has/VBZ
been/VBN
shown/VBN
that/IN
ANG/NN
produced/VBN
tRFs/NNS
that/DT
re-program/NN
translation/NN
and/CC
promote/VBP
the/DT
assembly/NN
of/IN
stress/NN
granules/NNS
./.
====================
As/IN
these/DT
events/NNS
help/VBP
cells/NNS
survive/VBP
under/IN
adverse/JJ
conditions/NNS
,/,
it/PRP
is/VBZ
possible/JJ
that/IN
ANG-induced/JJ
tRFs/NNS
may/MD
contribute/VB
to/TO
ANG-mediated/JJ
cancer/NN
cell/NN
proliferation/NN
[/(
48/CD
]/)
./.
====================
tRFs/NNS
have/VBP
also/RB
been/VBN
reported/VBN
to/TO
help/VB
cancer/NN
cells/NNS
to/TO
prevent/VB
apoptosome/JJ
formation/NN
by/IN
binding/VBG
to/TO
cytochrome/NN
c/NN
[/(
53/CD
]/)
./.
====================
Although/IN
tRNA/NN
metabolism/NN
is/VBZ
essential/JJ
for/IN
all/DT
human/JJ
cells/NNS
,/,
a/DT
number/NN
of/IN
neurological/JJ
disorders/NNS
are/VBP
caused/VBN
by/IN
defects/NNS
in/IN
tRNA/NN
metabolism/NN
and/CC
tRNA/NN
processing/NN
enzymes/NNS
./.
====================
ANG/NN
mutants/NNS
possessing/VBG
reduced/VBD
RNase/NN
activity/NN
were/VBD
implicated/VBN
in/IN
the/DT
pathogenesis/NN
of/IN
amyotrophic/JJ
lateral/JJ
sclerosis/NN
(/(
ALS/NNS
)/)
,/,
a/DT
fatal/JJ
neurodegenerative/JJ
disease/NN
[/(
54/CD
]/)
./.
====================
A/DT
subset/NN
of/IN
ALS-associated/JJ
ANG/NN
mutants/NNS
was/VBD
also/RB
found/VBD
in/IN
Parkinson/NN
's/POS
disease/NN
patients/NNS
[/(
55/CD
]/)
./.
====================
Administration/NN
of/IN
recombinant/JJ
ANG/NN
to/TO
cultured/VBN
neurons/NNS
protects/VBZ
them/PRP
from/IN
stress-induced/JJ
apoptosis/NN
and/CC
promotes/VBZ
the/DT
lifespan/JJ
and/CC
motor/NN
function/NN
of/IN
SOD1/NN
(/(
G93A/NN
)/)
mice/NNS
,/,
a/DT
laboratory/JJ
ALS/NNS
model/NN
./.
====================
In/IN
neurons/NNS
,/,
excessive/JJ
accumulation/NN
of/IN
some/DT
tRF-5/NN
series/NNS
members/NNS
that/IN
are/VBP
derived/VBN
from/IN
a/DT
specific/JJ
subset/NN
of/IN
tRNAs/NNS
(/(
Asp/NN
,/,
Glu/NNP
,/,
Gly/RB
,/,
His/NNP
,/,
Val/NN
,/,
and/CC
Lys/NNS
)/)
triggers/VBZ
a/DT
sustained/JJ
stress/NN
response/NN
leading/VBG
to/TO
neuronal/JJ
loss/NN
and/CC
links/NNS
aberrant/JJ
tRNA/NN
metabolism/NN
to/TO
the/DT
development/NN
of/IN
certain/JJ
forms/NNS
of/IN
intellectual/JJ
disability/NN
[/(
48/CD
]/)
./.
====================
tRFs/NNS
derived/VBN
from/IN
intron-containing/JJ
tRNAs/NNS
are/VBP
also/RB
strongly/RB
implicated/VBN
in/IN
neurodegeneration/NN
[/(
565758/CD
]/)
./.
====================
A/DT
study/NN
on/IN
mutant/JJ
mice/NNS
carrying/VBG
a/DT
catalytically/RB
inactive/JJ
form/NN
of/IN
the/DT
RNA/NN
kinase/NN
CLP1/NN
,/,
a/DT
component/NN
of/IN
the/DT
tRNA/NN
splicing/NN
endonuclease/NN
complex/NN
,/,
revealed/VBD
a/DT
neurological/JJ
disorder/NN
characterized/VBN
by/IN
progressive/JJ
loss/NN
of/IN
lower/JJR
spinal/JJ
motor/NN
neurons/NNS
./.
====================
Surprisingly/RB
,/,
mutant/JJ
mice/NNS
accumulate/VBP
a/DT
novel/JJ
class/NN
of/IN
tRFs/NNS
./.
====================
In/IN
addition/NN
,/,
homozygous/JJ
missense/NN
mutations/NNS
in/IN
CLP1/NN
(/(
R140H/NN
)/)
were/VBD
found/VBN
in/IN
patients/NNS
with/IN
pontocerebellar/JJ
hypoplasia/NN
,/,
a/DT
heterogeneous/JJ
group/NN
of/IN
inherited/VBN
neurodegenerative/JJ
disorders/NNS
characterized/VBN
by/IN
impaired/JJ
development/NN
of/IN
various/JJ
parts/NNS
of/IN
the/DT
brain/NN
./.
====================
These/DT
patients/NNS
were/VBD
identified/VBN
to/TO
suffer/VB
from/IN
severe/JJ
motor-sensory/JJ
defects/NNS
,/,
cortical/JJ
dysgenesis/NN
and/CC
microcephaly/RB
,/,
and/CC
exhibit/VBP
alterations/NNS
in/IN
tRNA/NN
splicing/NN
[/(
59/CD
]/)
./.
====================
On/IN
the/DT
cellular/JJ
level/NN
,/,
the/DT
R140A/NN
mutation/NN
leads/VBZ
to/TO
the/DT
depletion/NN
of/IN
mature/JJ
tRNAs/NNS
,/,
the/DT
accumulation/NN
of/IN
unspliced/JJ
pre-tRNAs/NNS
in/IN
patient-derived/JJ
induced/VBD
neurons/NNS
[/(
58/CD
]/)
and/CC
the/DT
accumulation/NN
of/IN
linear/JJ
tRNA/NN
introns/NNS
[/(
57/CD
]/)
./.
====================
Transfection/NN
of/IN
5'-unphosphorylated/JJ
tRF/NN
corresponding/VBG
to/TO
the/DT
3'-exon/JJ
of/IN
pre-tRNATyr/JJ
(/(
the/DT
natural/JJ
substrate/NN
of/IN
CLP1/NN
)/)
into/IN
patient/NN
cells/NNS
results/VBZ
in/IN
reduced/VBN
neuron/NN
survival/NN
under/IN
oxidative/JJ
stress/NN
compared/VBN
to/TO
the/DT
transfection/NN
of/IN
the/DT
5'-exon/JJ
,/,
which/WDT
had/VBD
no/DT
effect/NN
on/IN
viability/NN
[/(
58/CD
]/)
./.
====================
The/DT
kinase-dead/JJ
CLP1/NN
mice/NNS
accumulate/VBP
5'-leader-exon-tRFs/NNS
that/DT
sensitize/VBP
cells/NNS
to/TO
oxidative/JJ
stress/NN
and/CC
promote/VBP
cell/NN
death/NN
in/IN
a/DT
p53-dependent/JJ
fashion/NN
[/(
56/CD
]/)
./.
====================
While/IN
the/DT
exact/JJ
mechanistic/JJ
details/NNS
on/IN
the/DT
interplay/NN
between/IN
CLP1/NN
activity/NN
,/,
tRNA/NN
splicing/NN
and/CC
functions/NNS
of/IN
pre-tRNA-derived/JJ
tRFs/NNS
are/VBP
yet/RB
to/TO
be/VB
uncovered/JJ
,/,
these/DT
studies/NNS
provide/VBP
a/DT
basis/NN
for/IN
further/JJ
investigations/NNS
linking/VBG
aberrant/JJ
tRNA/NN
metabolism/NN
and/CC
development/NN
of/IN
neurodegeneration/NN
[/(
48/CD
]/)
./.
====================
Viruses/NNS
exploit/VBP
a/DT
number/NN
of/IN
strategies/NNS
to/TO
evade/VB
host/NN
immune/JJ
recognition/NN
and/CC
to/TO
facilitate/VB
viral/JJ
replication/NN
./.
====================
Some/DT
of/IN
these/DT
strategies/NNS
involve/VBP
viral-derived/JJ
or/CC
endogenous/JJ
cellular/JJ
ncRNAs/NNS
that/DT
interact/VBP
with/IN
host/NN
immune/JJ
responses/NNS
[/(
60/CD
]/)
./.
====================
We/PRP
have/VBP
demonstrated/VBN
that/IN
RSV/NN
,/,
the/DT
most/JJS
common/JJ
cause/VBP
of/IN
bronchiolitis/NN
and/CC
pneumonia/NN
in/IN
babies/NNS
,/,
employs/VBZ
a/DT
novel/JJ
mechanism/NN
to/TO
suppress/VB
antiviral/JJ
responses/NNS
via/IN
induction/NN
of/IN
some/DT
tRFs/NNS
[/(
561/CD
]/)
./.
====================
We/PRP
have/VBP
shown/VBN
that/IN
RSV/NN
infection/NN
in/IN
airway/NN
epithelial/JJ
cells/NNS
leads/VBZ
to/TO
the/DT
activation/NN
of/IN
endonuclease/NN
ANG/NN
,/,
subsequently/RB
inducing/VBG
abundant/JJ
production/NN
of/IN
tRFs/NNS
,/,
most/JJS
of/IN
which/WDT
belong/IN
to/TO
that/DT
tRF-5/NN
series/NN
./.
====================
The/DT
cleavage/NN
sites/NNS
by/IN
ANG/NN
are/VBP
preferentially/RB
adjacent/JJ
to/TO
the/DT
5'-end/NN
of/IN
the/DT
anticodon-loop/JJ
,/,
generating/VBG
tRF-5/NN
series/NN
./.
====================
These/DT
tRF-5s/NNS
are/VBP
localized/VBN
exclusively/RB
in/IN
the/DT
cellular/JJ
cytoplasm/NN
[/(
5/CD
]/)
./.
====================
At/IN
least/JJS
one/CD
of/IN
the/DT
tRFs/NNS
,/,
namely/RB
tRF5-GluCTC/NN
(/(
tRF-5/NN
derived/VBN
from/IN
tRNAGlu/NN
)/)
,/,
has/VBZ
a/DT
trans-gene/JJ
silencing/NN
function/NN
./.
====================
Significantly/RB
,/,
an/DT
antiviral/JJ
target/NN
suppressed/VBD
by/IN
tRF5-GluCTC/NN
downregulates/VBZ
RSV/NN
replication/NN
and/CC
significantly/RB
decreases/VBZ
the/DT
yield/NN
of/IN
infectious/JJ
viral/JJ
particles/NNS
produced/VBN
by/IN
infected/JJ
cells/NNS
,/,
demonstrating/VBG
a/DT
stimulatory/JJ
role/NN
for/IN
tRF5-GluCTC/NN
in/IN
RSV/NN
replication/NN
[/(
5/CD
]/)
./.
====================
Using/VBG
an/DT
elegant/JJ
biochemical/JJ
approach/NN
,/,
named/VBD
HITS-ABt/NN
(/(
hIgh-throughput/NN
sequencing/NN
of/IN
RNAs/NNS
associated/VBN
with/IN
biotinylated/VBN
tRF/NN
)/)
,/,
to/TO
capture/JJ
tRF5-GluCTC-containing/VBG
ribonucleoprotein/NN
complexes/NNS
combined/VBN
with/IN
bioinformatics/NNS
analysis/NN
,/,
we/PRP
have/VBP
identified/VBN
a/DT
number/NN
of/IN
potential/JJ
cellular/JJ
mRNA/NN
targets/NNS
of/IN
tRF5-GluCTC/NN
./.
====================
One/CD
of/IN
the/DT
candidate/NN
mRNAs/NNS
was/VBD
shown/VBN
to/TO
be/VB
a/DT
direct/JJ
target/NN
of/IN
tRF5-GluCTC/NN
./.
====================
Mechanistically/RB
,/,
tRF5-GluCTC/NN
recognizes/VBZ
a/DT
target/NN
site/NN
in/IN
the/DT
3'-untranslated/JJ
region/NN
of/IN
APOER2/NN
mRNA/NN
and/CC
suppresses/VBZ
its/PRP$
expression/NN
by/IN
an/DT
unknown/JJ
mechanism/NN
./.
====================
Further/RB
analysis/NN
identified/VBD
a/DT
previously/RB
unappreciated/JJ
role/NN
for/IN
APOER2/NN
protein/NN
in/IN
antiviral/JJ
defense/NN
against/IN
RSV/NN
infection/NN
[/(
61/CD
]/)
./.
====================
Thus/RB
,/,
we/PRP
have/VBP
illuminated/VBN
the/DT
roles/NNS
of/IN
tRFs/NNS
in/IN
host–virus/NN
interactions/NNS
and/CC
described/VBN
a/DT
novel/JJ
molecular/JJ
mechanism/NN
for/IN
host/NN
response/NN
regulation/NN
via/IN
gene/NN
targeting/VBG
at/IN
posttranscriptional/JJ
level/NN
,/,
proving/VBG
a/DT
potential/JJ
therapeutic/JJ
target/NN
to/TO
control/JJ
RSV/NN
replication/NN
by/IN
regulating/VBG
tRFs/NNS
induction/NN
./.
====================
As/IN
another/DT
example/NN
of/IN
tRFs/NNS
with/IN
a/DT
positive/JJ
effect/NN
on/IN
viral/JJ
replication/NN
,/,
a/DT
tRF-3/NN
derived/VBN
from/IN
tRNAPro/NN
(/(
tRF-3019/NN
)/)
has/VBZ
been/VBN
suggested/VBN
to/TO
function/VB
as/IN
a/DT
primer/NN
for/IN
reverse/JJ
transcription/NN
of/IN
human/JJ
T-cell/NN
leukemia/NN
virus-1/NN
[/(
62/CD
]/)
./.
====================
The/DT
induction/NN
of/IN
tRFs/NNS
is/VBZ
virus/NN
specific/JJ
,/,
as/IN
human/JJ
metapneumovirus/NN
,/,
a/DT
negative-sense/JJ
single/JJ
stranded/JJ
RNA/NN
virus/NN
belonging/VBG
to/TO
the/DT
Paramyxoviridae/NN
family/NN
[/(
63/CD
]/)
and/CC
frequent/JJ
cause/VBP
for/IN
lower/JJR
respiratory/JJ
tract/NN
infections/NNS
in/IN
young/JJ
children/NN
,/,
immunocompromised/VBN
patients/NNS
and/CC
older/JJR
adults/NNS
[/(
64656667/CD
]/)
,/,
did/VBD
not/RB
induce/VB
tRFs/NNS
but/CC
gradually/RB
enhanced/VBD
the/DT
expression/NN
percentage/NN
of/IN
miRNAs/NNS
in/IN
a/DT
time-dependent/JJ
fashion/NN
[/(
6/CD
]/)
./.
====================
The/DT
involvement/NN
of/IN
tRFs/NNS
in/IN
infectious/JJ
diseases/NNS
suggests/VBZ
that/IN
tRFs/NNS
may/MD
be/VB
targets/NNS
for/IN
the/DT
development/NN
of/IN
new/JJ
drugs/NNS
to/TO
control/VB
viral/JJ
replication/NN
./.
====================
The/DT
human/JJ
genome/NN
encodes/VBZ
hundreds/VBZ
of/IN
tRNA/NN
genes/NNS
and/CC
pseudogenes/NNS
./.
====================
In/IN
the/DT
past/NN
two/CD
decades/NNS
,/,
an/DT
increasing/VBG
number/NN
of/IN
reports/NNS
have/VBP
revealed/VBN
abundant/JJ
expression/NN
of/IN
functional/JJ
tRFs/NNS
;/:
thus/RB
,/,
it/PRP
now/RB
appears/VBZ
highly/RB
plausible/JJ
that/IN
cells/NNS
use/VBP
tRNAs/NNS
as/IN
a/DT
source/NN
for/IN
functional/JJ
sncRNAs/NNS
to/TO
modulate/VB
biological/JJ
processes/NNS
beyond/CC
its/PRP$
translation/NN
function/NN
./.
====================
It/PRP
is/VBZ
imperative/JJ
to/TO
discriminate/VB
functional/JJ
tRNA/NN
fragments/NNS
from/IN
``/CD
meaningless/NN
''/CD
degradation/NN
products/NNS
,/,
and/CC
to/TO
biochemically/RB
elucidate/VB
the/DT
factors/NNS
in/IN
their/PRP$
biogenesis/NN
as/IN
well/RB
as/IN
to/TO
determine/VB
their/PRP$
molecular/JJ
functions/NNS
./.
====================
Although/IN
tRFs/NNS
,/,
at/IN
least/JJS
the/DT
tRF-5s/NNS
induced/VBD
by/IN
RSV/NN
,/,
regulate/VBP
gene/NN
expression/NN
at/IN
post-transcriptional/JJ
stages/NNS
in/IN
the/DT
cytoplasm/NN
,/,
the/DT
precise/JJ
mechanism/NN
is/VBZ
yet/RB
to/TO
be/VB
clarified/VBN
./.
====================
Like/IN
miRNAs/NNS
,/,
tRFs/NNS
can/MD
repress/VB
target/NN
mRNAs/NNS
by/IN
inhibiting/VBG
their/PRP$
translation/NN
or/CC
facilitating/VBG
their/PRP$
decay/NN
./.
====================
These/DT
questions/NNS
can/MD
be/VB
answered/VBN
by/IN
analyzing/VBG
their/PRP$
localization/NN
,/,
identifying/VBG
their/PRP$
interacting/VBG
protein/NN
partners/NNS
besides/VBZ
Argonaute/NN
proteins/NNS
,/,
and/CC
examining/VBG
various/JJ
biological/JJ
phenomena/NNS
in/IN
response/NN
to/TO
the/DT
changes/NNS
in/IN
the/DT
expression/NN
of/IN
tRFs/NNS
./.
====================
Bioinformatics/NNS
studies/NNS
with/IN
the/DT
support/NN
from/IN
biochemical/JJ
assays/NNS
have/VBP
identified/VBN
numerous/JJ
novel/JJ
tRNA-interacting/VBG
proteins/NNS
[/(
68/CD
]/)
,/,
implying/VBG
that/DT
the/DT
biological/JJ
functions/NNS
of/IN
tRNAs/NNS
and/CC
their/PRP$
fragments/NNS
may/MD
be/VB
way/NN
beyond/CC
our/PRP$
expectations/NNS
./.
====================
Further/RB
combination/NN
of/IN
computational/JJ
and/CC
biochemical/JJ
efforts/NNS
will/MD
significantly/RB
advance/VB
our/PRP$
understanding/NN
of/IN
functional/JJ
tRFs/NNS
and/CC
expand/CC
our/PRP$
knowledge/NN
regarding/VBG
the/DT
tRNA/NN
world/NN
./.
====================
The/DT
availability/NN
of/IN
genome/NN
sequencing/NN
data/NNS
from/IN
patients/NNS
with/IN
diverse/JJ
conditions/NNS
has/VBZ
already/RB
led/VBD
to/TO
the/DT
identification/NN
of/IN
several/JJ
mutations/NNS
in/IN
tRNA/NN
genes/NNS
and/CC
in/IN
genes/NNS
involved/VBN
in/IN
tRNA/NN
biogenesis/NN
[/(
69/CD
]/)
./.
====================
The/DT
task/NN
now/RB
is/VBZ
to/TO
ascertain/VB
whether/IN
these/DT
mutations/NNS
indeed/RB
affect/VB
the/DT
repertoire/NN
of/IN
tRFs/NNS
and/CC
consequently/RB
the/DT
molecular/JJ
pathology/NN
of/IN
the/DT
diseases/NNS
./.
====================
Studies/NNS
on/IN
tRFs/NNS
are/VBP
still/RB
at/IN
a/DT
very/RB
early/JJ
stage/NN
./.
====================
Additional/JJ
functions/NNS
for/IN
tRFs/NNS
are/VBP
likely/JJ
to/TO
be/VB
discovered/VBN
continuously/RB
./.
====================
Improved/JJ
understanding/NN
of/IN
the/DT
functions/NNS
of/IN
tRFs/NNS
will/MD
provide/VB
valuable/JJ
insights/NNS
into/IN
human/JJ
physiology/NN
and/CC
pathophysiology/NN
./.
====================
Recognition/NN
of/IN
tRFs/NNS
as/IN
an/DT
important/JJ
class/NN
of/IN
functional/JJ
molecules/NNS
has/VBZ
not/RB
happened/VBN
until/IN
recently/RB
./.
====================
The/DT
apparent/JJ
presence/NN
of/IN
abundant/JJ
tRFs/NNS
in/IN
early/JJ
studies/NNS
with/IN
next/JJ
generation/NN
sequencing/NN
data/NNS
was/VBD
often/RB
ignored/VBN
./.
====================
However/RB
,/,
the/DT
combined/JJ
biochemical/JJ
evidence/NN
from/IN
many/JJ
years/NNS
of/IN
tRNA/JJ
biology/RB
studies/NNS
has/VBZ
brought/VBN
the/DT
field/JJ
to/TO
a/DT
previously/RB
unexpected/JJ
conceptual/JJ
consensus/NN
:/:
specific/JJ
tRFs/NNS
are/VBP
not/RB
simply/RB
random/RB
degradation/NN
products/NNS
but/CC
functional/JJ
molecules/NNS
based/VBN
on/IN
the/DT
following/VBG
observations/NNS
:/:
(/(
1/LS
)/)
in/IN
many/JJ
cases/NNS
,/,
tRFs/RB
do/VBP
not/RB
derive/JJ
from/IN
abundant/JJ
cellular/JJ
tRNAs/NNS
,/,
and/CC
the/DT
numbers/NNS
of/IN
tRFs/NNS
do/VBP
not/RB
correlate/VB
with/IN
the/DT
parental/JJ
tRNA/NN
gene/NN
copy/RB
numbers/NNS
;/:
(/(
2/LS
)/)
their/PRP$
fragmentation/NN
patterns/NNS
are/VBP
tRNA/RB
structure-dependent/JJ
;/:
(/(
3/LS
)/)
the/DT
fragmentation/NN
patterns/NNS
is/VBZ
determined/VBN
by/IN
the/DT
developmental/JJ
stage/NN
or/CC
cell/NN
conditions/NNS
;/:
and/CC
(/(
4/CD
)/)
it/PRP
is/VBZ
reported/VBN
that/IN
some/DT
tRFs/NNS
are/VBP
bound/VBN
to/TO
Argonaute/Piwi/NNP
proteins/NNS
,/,
well-known/RB
components/NNS
of/IN
the/DT
RNA-induced/JJ
silencing/VBG
complex/NN
[/(
213170717273/CD
]/)
./.
====================
The/DT
expression/NN
of/IN
tRFs/NNS
does/VBZ
not/RB
usually/RB
affect/VB
mature/JJ
tRNA/NN
pools/NNS
./.
====================
Instead/RB
,/,
it/PRP
is/VBZ
involved/VBN
in/IN
normal/JJ
biological/JJ
processes/NNS
beyond/CC
translation/NN
and/CC
in/IN
diseases/NNS
;/:
thus/RB
,/,
studies/NNS
of/IN
tRFs/NNS
have/VBP
provided/VBN
new/JJ
insights/NNS
into/IN
tRNA/NN
biology/NN
./.
====================
tRNA/NN
processing/NN
and/CC
classification/NN
of/IN
tRNA-derived/JJ
RNA/NN
fragments/NNS
(/(
tRFs/NNS
)/)
./.
====================
Biological/JJ
roles/NNS
of/IN
tRNA-derived/JJ
RNA/NN
fragments/NNS
(/(
tRFs/NNS
)/)
./.
====================
